Vebanvibart Biosimilar - Research Grade

Human

Severe acute respiratory syndrome coronavirus 2

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

The SARS-CoV-2 spike protein remains a primary antigen for neutralization, structural, and immunity studies in coronavirus research. This recombinant human IgG1 monoclonal is an unconjugated, non-therapeutic analog of vebanvibart directed against SARS-CoV-2 and is supplied strictly for research use only (RUO). It is purified to a low-endotoxin specification suitable for in vivo work and prepared in scalable milligram to gram quantities to keep bulk and high-throughput laboratories supplied. Researchers apply it in virus-neutralization assays, spike-binding studies, positive-control workflows, and preclinical infection and immune-response models, with no clinical purpose implied.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks